Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ADC Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN119504932A reveals a novel zinc bromide method for high-purity linker-drug synthesis, offering significant supply chain and cost advantages for ADC manufacturing.
Patent CN107531680B reveals a novel route for toxin intermediates, offering high optical purity and yield for cost reduction in ADC toxin manufacturing.